Physical vs. multidimensional frailty in older adults with and without heart failure.


Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
06 2020
Historique:
received: 20 02 2020
accepted: 08 03 2020
pubmed: 4 4 2020
medline: 22 6 2021
entrez: 4 4 2020
Statut: ppublish

Résumé

The assessment of frailty in older adults with heart failure (HF) is still debated. Here, we compare the predictive role and the diagnostic accuracy of physical vs. multidimensional frailty assessment on mortality, disability, and hospitalization in older adults with and without HF. A total of 1077 elderly (≥65 years) outpatients were evaluated with the physical (phy-Fi) and multidimensional (m-Fi) frailty scores and according to the presence or the absence of HF. Mortality, disability, and hospitalizations were assessed at baseline and after a 24 month follow-up. Cox regression analysis demonstrated that, compared with phy-Fi score, m-Fi score was more predictive of mortality [hazard ratio (HR) = 1.05 vs. 0.66], disability (HR = 1.02 vs. 0.89), and hospitalization (HR = 1.03 vs. 0.96) in the absence and even more in the presence of HF (HR = 1.11 vs. 0.63, 1.06 vs. 0.98, and 1.14 vs. 1.03, respectively). The area under the curve indicated a better diagnostic accuracy with m-Fi score than with phy-Fi score for mortality, disability, and hospitalizations, both in absence (0.782 vs. 0.649, 0.763 vs. 0.695, and 0.732 vs. 0.666, respectively) and in presence of HF (0.824 vs. 0.625, 0.886 vs. 0.793, and 0.812 vs. 0.688, respectively). The m-Fi score is able to predict mortality, disability, and hospitalizations better than the phy-Fi score, not only in absence but also in presence of HF. Our data also demonstrate that the m-Fi score has better diagnostic accuracy than the phy-Fi score. Thus, the use of the m-FI score should be considered for the assessment of frailty in older HF adults.

Identifiants

pubmed: 32243099
doi: 10.1002/ehf2.12688
pmc: PMC7261566
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1371-1380

Informations de copyright

© 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.

Références

Lancet. 2013 Mar 2;381(9868):752-62
pubmed: 23395245
Eur J Intern Med. 2016 Jun;31:3-10
pubmed: 27039014
Arch Gerontol Geriatr. 2010 Nov-Dec;51(3):323-8
pubmed: 20153534
Eur J Heart Fail. 2016 Aug;18(8):891-975
pubmed: 27207191
J Gerontol A Biol Sci Med Sci. 2007 Jul;62(7):722-7
pubmed: 17634318
J Am Coll Cardiol. 2014 Mar 4;63(8):747-62
pubmed: 24291279
J Am Geriatr Soc. 2013 Oct;61(10):1827-8
pubmed: 24117301
Eur J Intern Med. 2018 Oct;56:49-52
pubmed: 29526651
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
Circulation. 2016 May 24;133(21):2103-22
pubmed: 27067230
BMC Geriatr. 2008 Sep 30;8:24
pubmed: 18826625
Lancet. 2018 Feb 10;391(10120):572-580
pubmed: 29174292
Heart Fail Rev. 2013 Jul;18(4):529-51
pubmed: 23124913
Eur J Prev Cardiol. 2019 Jul;26(10):1115-1117
pubmed: 30722680
J Am Med Dir Assoc. 2018 Nov;19(11):1003-1008.e1
pubmed: 30076123
Arch Gerontol Geriatr. 2004 May-Jun;38(3):297-307
pubmed: 15066316
J Am Geriatr Soc. 2010 Aug;58(8):1433-40
pubmed: 20670379
Aging Clin Exp Res. 2017 Oct;29(5):913-926
pubmed: 28688080
Ann Epidemiol. 1995 Jul;5(4):270-7
pubmed: 8520708
J Am Coll Cardiol. 2017 Aug 8;70(6):776-803
pubmed: 28461007
Int J Cardiol. 2017 Jun 1;236:283-289
pubmed: 28215466
Eur J Heart Fail. 2019 Nov;21(11):1299-1305
pubmed: 31646718
ESC Heart Fail. 2020 Jun;7(3):1371-1380
pubmed: 32243099
J Am Coll Cardiol. 2018 May 1;71(17):1921-1936
pubmed: 29699619
Clin Interv Aging. 2018 May 14;13:913-927
pubmed: 29785098
Heart Fail Rev. 2016 Sep;21(5):549-65
pubmed: 26920682
Front Physiol. 2018 Apr 24;9:347
pubmed: 29740330
JACC Heart Fail. 2019 Apr;7(4):291-302
pubmed: 30738977

Auteurs

Gianluca Testa (G)

Department of Translational Medical Sciences, University of Naples "Federico II", Via S. Pansini, 80131, Naples, Italy.
Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy.

Francesco Curcio (F)

Department of Translational Medical Sciences, University of Naples "Federico II", Via S. Pansini, 80131, Naples, Italy.

Ilaria Liguori (I)

Department of Translational Medical Sciences, University of Naples "Federico II", Via S. Pansini, 80131, Naples, Italy.

Claudia Basile (C)

Department of Translational Medical Sciences, University of Naples "Federico II", Via S. Pansini, 80131, Naples, Italy.

Martina Papillo (M)

Department of Translational Medical Sciences, University of Naples "Federico II", Via S. Pansini, 80131, Naples, Italy.

Carlo Gabriele Tocchetti (CG)

Department of Translational Medical Sciences, University of Naples "Federico II", Via S. Pansini, 80131, Naples, Italy.

Gianlugi Galizia (G)

Department of Translational Medical Sciences, University of Naples "Federico II", Via S. Pansini, 80131, Naples, Italy.
IRCCS Salvatore Maugeri Foundation, Scientific Institute of Veruno, Novara, Italy.

David Della-Morte (D)

Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Department of Human Sciences and Quality of Life Promotion, San Raffaele Roma Open University, Rome, Italy.

Gaetano Gargiulo (G)

Division of Internal Medicine, AOU San Giovanni di Dio e Ruggi di Aragona, Salerno, Italy.

Francesco Cacciatore (F)

Department of Translational Medical Sciences, University of Naples "Federico II", Via S. Pansini, 80131, Naples, Italy.

Domenico Bonaduce (D)

Department of Translational Medical Sciences, University of Naples "Federico II", Via S. Pansini, 80131, Naples, Italy.

Pasquale Abete (P)

Department of Translational Medical Sciences, University of Naples "Federico II", Via S. Pansini, 80131, Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH